The island has maintained some of the lowest case rates in the world throughout the pandemic - lasting more than 200 days in 2020 without a single case.
Hong Kong, struggling with its worst COVID-19 outbreak since the pandemic began, will test every one of its 7.5 million people for the coronavirus three times next month, the city’s leader said Tuesday.
Medicines Patent Pool, an organization supported by the U.N., announced on Thursday that over two dozen generic drug makers will soon begin producing Merck's COVID-19 pill to make the treatment more accessible in developing countries.
The organization said that 27 generic drug makers would produce the pill for 105 developing countries. Specifically, agreements the companies signed allow them to make both molnupiravir's raw ingredients as well as the final product.
Molnupiravir is the COVID-19 treatment developed by Merck and Ridgeback Therapeutics. For patients with early signs of COVID-19, the pill is believed to cut the hospitalization rates in half.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XHWGLJIY65NULI2Z6X3TC4BML4.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LU6MDMAXWZPMBHOPDSDRH76TOQ.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/D77I3QSHGBKN5CHT6VTMU4ZF2E.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XMDQVJIL6FM3VEMYWP7W6NRFAA.jpg)
